Zepbound Tirzepatide Injection Prefilled Syringes 2.5 mg/0.5 mL Pen-Style (4-Pack)
Zepbound Tirzepatide 2.5mg/0.5mL prefilled syringes (4-pack) for weekly subcutaneous use. FDA-approved dual-action treatment for Type 2 diabetes. RX & refrigeration required.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Zepbound Tirzepatide is a breakthrough injectable medication specifically developed to manage type 2 diabetes in adults. This FDA-approved treatment, manufactured by Sanofi, combines the power of two essential hormone receptor agonists—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Together, they effectively reduce blood glucose levels by enhancing insulin secretion and minimizing glucose production in the liver.
Each package contains four prefilled, pen-style syringes containing 2.5 mg/0.5 mL of tirzepatide, designed for once-weekly subcutaneous injection. The medication is user-friendly and allows for convenient, at-home administration under a healthcare provider’s guidance.
Tirzepatide not only helps regulate blood sugar levels but also reduces appetite and supports weight loss, a valuable benefit for many patients with type 2 diabetes. Clinical trials have shown that Zepbound can significantly improve glycemic control and is well tolerated with a low risk of hypoglycemia when used as directed.
Key Features:
FDA-approved dual-action medication for type 2 diabetes
Combines GLP-1 and GIP receptor agonists
Once-weekly injection in prefilled, pen-style syringes
May help with weight management
Pack of 4 prefilled syringes (2.5 mg/0.5 mL each)
Refrigerated item – recipient must be present upon delivery
Prescription (RX) required
Directions for Use:
Inject subcutaneously into the abdomen, thigh, or upper arm once per week. Rotate injection sites regularly to avoid irritation. Only use the product under the supervision of a healthcare provider. Follow proper injection technique using sterile supplies and dispose of used syringes in a sharps container.
Important Notes:
For use in type 2 diabetes only. Not suitable for type 1 diabetes or diabetic ketoacidosis.
Common side effects may include nausea, vomiting, diarrhea, and mild injection site reactions.
Inform your healthcare provider of all current medications to avoid potential interactions.
Maintain a healthy diet and exercise routine to maximize the effectiveness of treatment.
Keep product refrigerated and ensure prompt delivery reception.
Zepbound Tirzepatide offers a convenient, effective way to improve glycemic control in adults with type 2 diabetes, supporting a healthier lifestyle with fewer daily injections.















Reviews
There are no reviews yet.